Apicidin

histone deacetylase inhibitor

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

Supporting references

Contradictory references

AI-suggested references

Clinical trials

Apicidin is a histone deacetylase inhibitor. It is being investigated as a carcinoma cell growth inhibitor.

Regarding SARS-CoV-2, our AIM tool found the data that apicidin could help against SARS-CoV-2 by modulating its intearctors.

Link	Tested on	Impact factor	Notes	Publication date
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing Small molecule	in silico	42.78		Apr/30/2020